Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine PIEB vs CEI for Labor Analgesia
NCT05781854Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- May 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in labor pain (2 arms), sponsored by Assiut University. Primary endpoint: Total volume of local anesthetic received at 24 hours. Started May 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT05781854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781854.